Evolve Pharmacology Practice Test

Difficulty breathing is the most concerning finding in a patient beginning treatment with opioids due to the respiratory depressant effects that these medications can produce. Opioids work by binding to specific receptors in the brain and spinal cord to alleviate pain, but this action can also dampen the respiratory drive, leading to inadequate ventilation. As a result, patients may experience shallow or slowed breathing, which can pose a serious risk of hypoxia and respiratory failure. Monitoring for signs of respiratory distress is crucial when initiating opioid therapy to ensure patient safety.

In contrast, while dry mouth and constipation are common side effects of opioids and warrant management, they are generally not life-threatening. Increased sensitivity to pain, known as opioid-induced hyperalgesia, can occur in some patients with prolonged opioid use but is also not immediately threatening compared to respiratory difficulties. Therefore, any indication of difficulty breathing must be addressed promptly, making it the most alarming finding in this context.